Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhong Sheng Tong
Observed names:
Z S Tong,
Z Tong,
Z. Tong,
Zhong-Sheng Tong,
Zhong-sheng Tong
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Chinese Academy of Medical Sciences & Peking Union Medical College,
Fudan University,
Tianjin Medical University Cancer Institute and Hospital,
Changhai Hospital,
Beijing Hospital,
Tongji Hospital,
Tianjin Medical University
show all 7
ORCID:
0000-0002-8869-2691
Observed ORCID:
0000-0002-8869-2691
OpenAlex ID:
A5020905743
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2– advanced breast cancer: the multinational randomized phase III study
2020
·
Qing Yuan Zhang
, Tao Sun
, et al.
·
Therapeutic Advances in Medical Oncology
·
115
Poorer Survival of Male Breast Cancer Compared with Female Breast Cancer Patients May Be Due to Biological Differences
2013
·
X. Chen
, X. Liu
, et al.
·
Japanese Journal of Clinical Oncology
·
56
Comparison of the clinical and prognostic features of primary breast sarcomas and malignant phyllodes tumor
2014
·
F. Wang
, Y. Jia
, et al.
·
Japanese Journal of Clinical Oncology
·
44
LBA19 Pyrotinib or placebo in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer (PHILA): A randomized phase III trial
2022
·
B. Xu
, M. Yan
, et al.
·
Annals of Oncology
·
20
PDF
Irradiation after Surgery for Breast Cancer Patients with Primary Tumours and One to Three Positive Axillary Lymph Nodes: Yes or No?
2013
·
C. Lu
, H. Xu
, et al.
·
Current Oncology
·
19
PDF
LBA16 Dalpiciclib plus letrozole or anastrozole as first-line treatment for HR+/HER2- advanced breast cancer (DAWNA-2): A phase III trial
2022
·
B. Xu
, Q.Y. Zhang
, et al.
·
Annals of Oncology
·
15
PDF
[Prognosis analysis of primary breast diffuse large B cell lymphoma].
2019
·
Y H Zhu
, W J Meng
, et al.
·
PubMed
·
6
Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study.
2012
·
Bing-he Xu
, Ze-fei Jiang
, et al.
·
PubMed
·
4
[Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer].
2008
·
Shu-Fen Li
, Xu Wang
, et al.
·
PubMed
·
4
349MO Results from a phase Ia/Ib Study of ESG401, a novel Trop2 antibody-drug conjugate, in patients with different subtypes of metastatic breast cancer
2024
·
F. Ma
, F. Qiu
, et al.
·
Annals of Oncology
·
3
PDF
Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patients.
2015
·
Peng Yuan
, Li-Jun Di
, et al.
·
PubMed
·
3
Capecitabine (X) combined with vinorelbine (V) in Chinese patients (pts) with metastatic breast cancer (MBC)
2004
·
B. Xu
, L. Tian
, et al.
·
Journal of Clinical Oncology
·
3
[Gemcitabine long-term maintenance chemotherapy benefits patients with survival: a multicenter, real-world study of advanced breast cancer treatment in China].
2024
·
J Yue
, G H Song
, et al.
·
PubMed
·
2
235P Efficacy and safety of first-line therapy with fulvestrant or exemestane for postmenopausal ER+/HER2- advanced breast cancer patients after adjuvant nonsteroidal aromatase inhibitor treatment: A randomized, open-label, multicenter study
2021
·
J. Wang
, B. Xu
, et al.
·
Annals of Oncology
·
2
[MicroRNAs Regulation of Cancer Stem Cells].
2015
·
Ju-Ping Zhang
, Yong-Sheng Jia
, et al.
·
PubMed
·
2
[Research Progress in Mixed Lineage Kinase Domain-Like].
2015
·
Wang Fang
, Zhong-Sheng Jia
, et al.
·
PubMed
·
1
Cox multivariate regression analysis on prognosis of elderly patients with breast cancer
2013
·
Mei Qing Qiu
, Zhong Sheng Tong
, et al.
·
Shiyong zhongliu zazhi
·
1
Capecitabine (X) plus vinorelbine (N) as second-line therapy in Chinese patients (pts) with metastastic breast cancer (MBC)
2006
·
B. Xu
, L. Tian
, et al.
·
Journal of Clinical Oncology
·
1
Sacituzumab tirumotecan versus chemotherapy in previously treated locally recurrent or metastatic triple-negative breast cancer: final overall survival analysis of the Phase III OptiTROP-Breast01
2026
·
B. Xu
, Y. Yin
, et al.
·
Annals of Oncology
PDF
518P Efficacy and safety of treatments in HR+HER2- advanced breast cancer after cyclin-dependent kinase 4/6 inhibitors progression: A network meta-analysis and scoping review
2025
·
Z. Tong
, L. Zhang
, et al.
·
Annals of Oncology
Efficacy of neoadjuvant chemotherapy in patients with triple-negative breast cancer and prognostic analysis
2014
·
Li Zhou
, Ye Shi
, et al.
·
Tumori
Clinical features and prognostic analysis of 117 breast cancer patients with first metastasis to the lung
2012
·
Mei Qing Qiu
, Zhong Sheng Tong
, et al.
·
Tumori
[The research progress of iron metabolism in cancer].
2012
·
Can Lu
, Zhong-Sheng Tong
, et al.
·
PubMed
Analysis of clinicopathological features and prognostic factors of patients with metastatic breast cancer
2012
·
Qian Yu
, Zhong Sheng Tong
, et al.
·
Tumori
Inhibitory effects of paclitaxel liposome on ovarian cancer cell
2012
·
Li Zhang
, Zhong Sheng Tong
, et al.
·
Shiyong zhongliu zazhi
Show more works
View as search
Works count:
34
Citation count:
301
H-index:
6
I10-index:
6
Year
Topic
Type